Free Trial

Centene (CNC) Stock Price, News & Analysis

Centene logo
$38.83 +1.19 (+3.16%)
As of 10:48 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$38.24
$39.28
50-Day Range
$25.20
$38.71
52-Week Range
$25.08
$73.50
Volume
3.90 million shs
Average Volume
9.41 million shs
Market Capitalization
$19.07 billion
P/E Ratio
9.62
Dividend Yield
N/A
Price Target
$39.07
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 88% of companies evaluated by MarketBeat, and ranked 125th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on 3 buy ratings, 13 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Centene has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 7.43% in the coming year, from $6.86 to $7.37 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is 9.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.31.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is 9.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.89.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 1.57. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    4.04% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 0.67%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.04% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 0.67%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Centene has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Centene this week, compared to 35 articles on an average week.
  • Search Interest

    Only 63 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days.
  • MarketBeat Follows

    23 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 283% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have bought more of their company's stock than they have sold. Specifically, they have bought $738,945.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.36% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

Centene (CNC) Gets a Hold from Cantor Fitzgerald
The Tiny Stock Set to Soar with Musk's AI Ambitions
The Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires in history, one tiny AI stock is flying under the radar. While you can't invest directly, we've pinpointed a stock poised to benefit immensely from his plans.tc pixel
What the Options Market Tells Us About Centene
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $60.58 at the start of the year. Since then, CNC shares have decreased by 37.8% and is now trading at $37.66.

Centene Corporation (NYSE:CNC) issued its quarterly earnings data on Friday, July, 25th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of $0.23 by $0.39. The company's revenue for the quarter was up 22.4% compared to the same quarter last year.
Read the conference call transcript
.

Centene's stock split on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were issued to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Centene: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more.

Centene's top institutional shareholders include Praxis Investment Management Inc. (0.01%), Grove Bank & Trust, Nilsine Partners LLC and Aaron Wealth Advisors LLC. Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Theodore R Samuels II, Christopher J Coughlin, Thomas Greco, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
7/25/2025
Today
10/07/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
CIK
1071739
Employees
60,500
Year Founded
1984

Price Target and Rating

High Price Target
$73.00
Low Price Target
$28.00
Potential Upside/Downside
+3.7%
Consensus Rating
Hold
Rating Score (0-4)
2.06
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.04
Trailing P/E Ratio
9.32
Forward P/E Ratio
5.49
P/E Growth
1.57
Net Income
$3.31 billion
Net Margins
1.15%
Pretax Margin
1.55%
Return on Equity
9.57%
Return on Assets
3.10%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.10
Quick Ratio
1.10

Sales & Book Value

Annual Sales
$163.07 billion
Price / Sales
0.11
Cash Flow
$9.63 per share
Price / Cash Flow
3.91
Book Value
$52.49 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
491,130,000
Free Float
489,365,000
Market Cap
$18.50 billion
Optionable
Optionable
Beta
0.48

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:CNC) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners